313 related articles for article (PubMed ID: 37507944)
1. Rising Influence of Nanotechnology in Addressing Oxidative Stress-Related Liver Disorders.
Padmanaban S; Pully D; Samrot AV; Gosu V; Sadasivam N; Park IK; Radhakrishnan K; Kim DK
Antioxidants (Basel); 2023 Jul; 12(7):. PubMed ID: 37507944
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Oxidative Stress and Antioxidants Balance in Fatty Liver Disease.
García-Ruiz C; Fernández-Checa JC
Hepatol Commun; 2018 Dec; 2(12):1425-1439. PubMed ID: 30556032
[TBL] [Abstract][Full Text] [Related]
3. Hepatic AMPK signaling dynamic activation in response to REDOX balance are sentinel biomarkers of exercise and antioxidant intervention to improve blood glucose control.
Wu M; Zhao A; Yan X; Gao H; Zhang C; Liu X; Luo Q; Xie F; Liu S; Shi D
Elife; 2022 Sep; 11():. PubMed ID: 36155132
[TBL] [Abstract][Full Text] [Related]
4. ROS-scavenging nanomedicine for "multiple crosstalk" modulation in non-alcoholic fatty liver disease.
Xin X; Li J; Wu W; Zhao P; Yang Y; Zhu Y; Ren L; Qin C; Yin L
Biomater Sci; 2023 May; 11(10):3709-3725. PubMed ID: 37039546
[TBL] [Abstract][Full Text] [Related]
5. Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis.
Branković M; Jovanović I; Dukić M; Radonjić T; Oprić S; Klašnja S; Zdravković M
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563534
[TBL] [Abstract][Full Text] [Related]
6. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.
Mukhopadhyay P; Horváth B; Rajesh M; Varga ZV; Gariani K; Ryu D; Cao Z; Holovac E; Park O; Zhou Z; Xu MJ; Wang W; Godlewski G; Paloczi J; Nemeth BT; Persidsky Y; Liaudet L; Haskó G; Bai P; Boulares AH; Auwerx J; Gao B; Pacher P
J Hepatol; 2017 Mar; 66(3):589-600. PubMed ID: 27984176
[TBL] [Abstract][Full Text] [Related]
7. New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress.
Ferro D; Baratta F; Pastori D; Cocomello N; Colantoni A; Angelico F; Del Ben M
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32927776
[TBL] [Abstract][Full Text] [Related]
8. Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH).
Takaki A; Kawai D; Yamamoto K
Int J Mol Sci; 2013 Oct; 14(10):20704-28. PubMed ID: 24132155
[TBL] [Abstract][Full Text] [Related]
9. The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes.
Al-Gubory KH; Fowler PA; Garrel C
Int J Biochem Cell Biol; 2010 Oct; 42(10):1634-50. PubMed ID: 20601089
[TBL] [Abstract][Full Text] [Related]
10. [Role of oxidative stress in non-alcoholic steatohepatitis].
Mitsuyoshi H; Itoh Y; Okanoue T
Nihon Rinsho; 2006 Jun; 64(6):1077-82. PubMed ID: 16768112
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase 1 and oxidative stress in paediatric non-alcoholic steatohepatitis.
Desai S; Baker SS; Liu W; Moya DA; Browne RW; Mastrandrea L; Baker RD; Zhu L
Liver Int; 2014 Jan; 34(1):110-7. PubMed ID: 24028323
[TBL] [Abstract][Full Text] [Related]
12. The promising future of nano-antioxidant therapy against environmental pollutants induced-toxicities.
Eftekhari A; Dizaj SM; Chodari L; Sunar S; Hasanzadeh A; Ahmadian E; Hasanzadeh M
Biomed Pharmacother; 2018 Jul; 103():1018-1027. PubMed ID: 29710659
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine in the ROS-mediated pathophysiology: Applications and clinical advances.
Nash KM; Ahmed S
Nanomedicine; 2015 Nov; 11(8):2033-40. PubMed ID: 26255114
[TBL] [Abstract][Full Text] [Related]
14. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation.
Chung HK; Kim YK; Park JH; Ryu MJ; Chang JY; Hwang JH; Lee CH; Kim SH; Kim HJ; Kweon GR; Kim KS; Shong M
Liver Int; 2015 Apr; 35(4):1341-53. PubMed ID: 25443620
[TBL] [Abstract][Full Text] [Related]
15. Nano-nutraceuticals to Combat Oxidative Stress: Unlocking Newer Paradigms in Adjuvant Therapy.
Pooja ; Pandey M; Kumar T; Goswami H; Kumari R; Kumara S; Jain N; Gorain B; Maurya PK; Chawla V; Chawla PA
Curr Top Med Chem; 2024 Apr; ():. PubMed ID: 38757334
[TBL] [Abstract][Full Text] [Related]
16. Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2/NQO-1 pathway.
Kang Y; Song Y; Luo Y; Song J; Li C; Yang S; Guo J; Yu J; Zhang X
Free Radic Biol Med; 2022 Nov; 192():25-36. PubMed ID: 36096356
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation.
Farzanegi P; Dana A; Ebrahimpoor Z; Asadi M; Azarbayjani MA
Eur J Sport Sci; 2019 Aug; 19(7):994-1003. PubMed ID: 30732555
[TBL] [Abstract][Full Text] [Related]
18. ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury.
Yu H; Jin F; Liu D; Shu G; Wang X; Qi J; Sun M; Yang P; Jiang S; Ying X; Du Y
Theranostics; 2020; 10(5):2342-2357. PubMed ID: 32104507
[TBL] [Abstract][Full Text] [Related]
19. INTENSITY OF THE ANTIOXIDANT PROTECTION SYSTEM AND OXIDATIVE STRESS FACTORS IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS DEPENDING ON THE FORM OF CHRONIC KIDNEY DISEASE.
Khukhlina O; Antoniv A; Kanovska L; Matushchak M; Vivsyannuk V
Georgian Med News; 2018 Mar; (276):71-76. PubMed ID: 29697385
[TBL] [Abstract][Full Text] [Related]
20. Glycine protects against high sucrose and high fat-induced non-alcoholic steatohepatitis in rats.
Zhou X; Han D; Xu R; Wu H; Qu C; Wang F; Wang X; Zhao Y
Oncotarget; 2016 Dec; 7(49):80223-80237. PubMed ID: 27784003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
